Hangzhou Tigermed Consulting Co (FRA:5HZ1) Cyclically Adjusted FCF per Share: €0.07 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:5HZ1 Hangzhou Tigermed Consulting Co Ltd FRA:5HZ1
87 GF Score
Price €4.08
GF Value €5.05
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Hangzhou Tigermed Consulting Co Cyclically Adjusted FCF per Share?

Hangzhou Tigermed Consulting Co FRA:5HZ1 -1.45% 87 Cyclically Adjusted FCF per Share is €0.07 as of Mar. 2026. GuruFocus rates FRA:5HZ1 with a GF Score™ of 87/100 and a GF Value™ of €5.05 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Hangzhou Tigermed Consulting Co's adjusted free cash flow per share for the three months ended in Mar. 2026 was €0.041. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €0.07 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Hangzhou Tigermed Consulting Co's average Cyclically Adjusted FCF Growth Rate was 16.20% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 14.20% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 18.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Hangzhou Tigermed Consulting Co was 22.30% per year. The lowest was 14.20% per year. And the median was 18.40% per year.

As of today (2026-07-29), Hangzhou Tigermed Consulting Co's current stock price is €4.08. Hangzhou Tigermed Consulting Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €0.07. Hangzhou Tigermed Consulting Co's Cyclically Adjusted Price-to-FCF of today is 58.29.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Hangzhou Tigermed Consulting Co was 543.89. The lowest was 45.26. And the median was 108.19.


Hangzhou Tigermed Consulting Co  (FRA:5HZ1) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Hangzhou Tigermed Consulting Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=4.08/0.07
=58.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Hangzhou Tigermed Consulting Co was 543.89. The lowest was 45.26. And the median was 108.19.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Hangzhou Tigermed Consulting Co Cyclically Adjusted FCF per Share Related Terms


Hangzhou Tigermed Consulting Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Hangzhou Tigermed Consulting Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hangzhou Tigermed Consulting Co Cyclically Adjusted FCF per Share Chart

Hangzhou Tigermed Consulting Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.06 0.06 0.05 0.07

Hangzhou Tigermed Consulting Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.06 0.07 0.07 0.07

FRA:5HZ1 vs TMO, DHR, IDXX: Cyclically Adjusted FCF per Share Comparison

For the Diagnostics & Research subindustry, Hangzhou Tigermed Consulting Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hangzhou Tigermed Consulting Co Cyclically Adjusted Price-to-FCF vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Hangzhou Tigermed Consulting Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Hangzhou Tigermed Consulting Co's Cyclically Adjusted Price-to-FCF falls into.


FRA:5HZ1
87GF Score
Hangzhou Tigermed Consulting Co Ltd FRA:5HZ1
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hangzhou Tigermed Consulting Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hangzhou Tigermed Consulting Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.041/116.3033*116.3033
=0.041

Current CPI (Mar. 2026) = 116.3033.

Hangzhou Tigermed Consulting Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.006 101.400 0.007
201609 0.005 102.400 0.006
201612 0.020 102.600 0.023
201703 0.016 103.200 0.018
201706 -0.001 103.100 -0.001
201709 0.003 104.100 0.003
201712 0.032 104.500 0.036
201803 0.012 105.300 0.013
201806 0.013 104.900 0.014
201809 0.035 106.600 0.038
201812 0.025 106.500 0.027
201903 0.004 107.700 0.004
201906 0.007 107.700 0.008
201909 0.029 109.800 0.031
201912 0.032 111.200 0.033
202003 0.009 112.300 0.009
202006 0.019 110.400 0.020
202009 0.031 111.700 0.032
202012 0.068 111.500 0.071
202103 0.016 112.662 0.017
202106 0.029 111.769 0.030
202109 0.024 112.215 0.025
202112 0.096 113.108 0.099
202203 0.040 114.335 0.041
202206 -0.013 114.558 -0.013
202209 0.057 115.339 0.057
202212 0.063 115.116 0.064
202303 -0.009 115.116 -0.009
202306 0.041 114.558 0.042
202309 0.035 115.339 0.035
202312 0.056 114.781 0.057
202403 0.005 115.227 0.005
202406 -0.009 114.781 -0.009
202409 0.048 115.785 0.048
202412 0.068 114.893 0.069
202503 0.022 115.116 0.022
202506 0.023 114.907 0.023
202509 0.036 115.471 0.036
202512 0.049 115.832 0.049
202603 0.041 116.303 0.041

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €0.07 mean?
Hangzhou Tigermed Consulting Co (FRA:5HZ1) has a Cyclically Adjusted FCF per Share of €0.07 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Hangzhou Tigermed Consulting Co and its competitors.
Is Hangzhou Tigermed Consulting Co's Cyclically Adjusted FCF per Share too high?
Hangzhou Tigermed Consulting Co's current Cyclically Adjusted FCF per Share is €0.07. Overall, Hangzhou Tigermed Consulting Co has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hangzhou Tigermed Consulting Co's Cyclically Adjusted FCF per Share compare to TMO and DHR?
Hangzhou Tigermed Consulting Co's Cyclically Adjusted FCF per Share of €0.07 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted FCF per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Hangzhou Tigermed Consulting Co and its competitors. Hangzhou Tigermed Consulting Co's current Cyclically Adjusted FCF per Share is €0.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hangzhou Tigermed Consulting Co stock overvalued right now?
Based on GuruFocus' analysis, Hangzhou Tigermed Consulting Co (FRA:5HZ1) is currently considered Modestly Undervalued. The stock's GF Value™ is €5.05, compared to a current price of €4.08 — trading 19.2% below its estimated fair value. The current Cyclically Adjusted FCF per Share is €0.07. Hangzhou Tigermed Consulting Co's overall GF Score™ is 87/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Hangzhou Tigermed Consulting Co (FRA:5HZ1), the current Cyclically Adjusted FCF per Share is €0.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hangzhou Tigermed Consulting Co (FRA:5HZ1) Overvalued in 2026?

Based on GuruFocus' analysis, Hangzhou Tigermed Consulting Co stock appears to be undervalued. The current stock price of €4.08 is trading 19.2% below its estimated GF Value™ of €5.05. GuruFocus considers Hangzhou Tigermed Consulting Co to be Modestly Undervalued.

Key valuation signals for FRA:5HZ1:

  • Cyclically Adjusted FCF per Share: €0.07
  • GF Value™: €5.05 vs. price of €4.08 (19.2% below fair value)
  • GF Score™: 87/100 with 5 warning signs

No single metric tells the full story. See the FRA:5HZ1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hangzhou Tigermed Consulting Co Business Description

Other Exchanges 03347:Hong Kong300347:China
Address No. 508 Lujiatan Street, Room 601-610, 6th Floor, Puyan Sub-District, Binjiang District, Zhejiang Province, Hangzhou, CHN
Hangzhou Tigermed Consulting Co Ltd is a China-based provider of comprehensive biopharmaceutical R&D services, with an expanding world-wide presence. The Group is principally engaged in CRO services.
87GF Score

Get the complete analysis for FRA:5HZ1

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.08
Price
€5.05
GF Value